Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-04753299 是一种有效的、选择性的LpxC 抑制剂。PF-04753299 对淋球菌分离株具有杀菌作用,对大肠杆菌、铜绿假单胞菌和肺炎菌株的抑制的MIC90值分别为 2 μg/ml、4 μg/ml 和 16 μg/ml。PF-04753299 用于革兰氏阴性菌感染的研究。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 783 | 现货 | ||
2 mg | ¥ 1,170 | 现货 | ||
5 mg | ¥ 1,830 | 现货 | ||
10 mg | ¥ 2,650 | 现货 | ||
25 mg | ¥ 4,430 | 现货 | ||
50 mg | ¥ 6,330 | 现货 |
产品描述 | PF-04753299 is a potent and selective inhibitor of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC), demonstrating bactericidal effects against gonococcal isolates. It exhibits inhibitory activity against E. coli, P. aeruginosa, and K. pneumoniae, with minimum inhibitory concentration (MIC) 90 values of 2 μg/ml, 4 μg/ml, and 16 μg/ml, respectively. This compound is utilized in researching gram-negative bacterial infections [1]. |
体内活性 | Mice were administered PF-04753299 (subcutaneous dose; vehicle: 40% β cyclodextrin in water) 0.5 and 4 h after an intraperitoneal challenge of Pseudomonas aeruginosa strain UC12120, a penicillin-resistant, quinolone-sensitive clinical isolate (1a MIC = 0.25 μg/mL). At 24 h postinfection, the animals were sacrificed and the bacterial burden in the spleen was determined. The drug dose providing 50% bacterial burden reduction relative to untreated animals (ED50) was determined to be 35 mg/kg[2]. |
分子量 | 347.43 |
分子式 | C18H21NO4S |
CAS No. | 1289620-49-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 18mg/mL (51.8mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.8783 mL | 14.3914 mL | 28.7828 mL | 71.9569 mL |
5 mM | 0.5757 mL | 2.8783 mL | 5.7566 mL | 14.3914 mL | |
10 mM | 0.2878 mL | 1.4391 mL | 2.8783 mL | 7.1957 mL | |
20 mM | 0.1439 mL | 0.7196 mL | 1.4391 mL | 3.5978 mL | |
50 mM | 0.0576 mL | 0.2878 mL | 0.5757 mL | 1.4391 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
PF-04753299 1289620-49-0 Others PF04753299 PF 04753299 Inhibitor inhibitor inhibit